ASLN Company Profile and Key Details
ASLAN Pharmaceuticals Limited
ASLN Stock Price Chart
Stock Price Today
ASLAN Pharmaceuticals Limited (ASLN) stock declined over -14.27%, trading at $0.60 on NASDAQ, down from the previous close of $0.70. The stock opened at $0.63, fluctuating between $0.60 and $0.70 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.
Company Information
| Employees | 35 |
| Beta | 1.4 |
| Sales or Revenue | $12.00M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) stock price is $0.60 in the last trading session. During the trading session, ASLN stock reached the peak price of $0.70 while $0.60 was the lowest point it dropped to. The percentage change in ASLN stock occurred in the recent session was -14.27% while the dollar amount for the price change in ASLN stock was -$0.10.
The NASDAQ listed ASLN is part of Biotechnology industry that operates in the broader Healthcare sector. ASLAN Pharmaceuticals Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Kiran Kumar Asarpota
Chief Operating Officer & Head of Fin.
Chi-Chin Wang
IR & Corporation Devel. Director
Dr. Alexandre Kaoukhov M.D.
Chief Medical Officer
Charlie Hsu
Investor Relations Director
Mr. Ben Goodger
Gen. Counsel
Dr. Carl Alan Jason Morton Firth EMBA, Ph.D.
Founder, Chief Executive Officer & Executive Director
Mr. Stephen Doyle
Chief Bus. Officer
ASLN's closing price is 26.32% higher than its 52-week low of $0.48 where as its distance from 52-week high of $17.04 is -96.48%.
Number of ASLN employees currently stands at 35.
Official Website of ASLN is: https://aslanpharma.com
ASLN could be contacted at phone 656 222 4235 and can also be accessed through its website. ASLN operates from 83 Clemenceau Avenue, Singapore, 239920, Singapore.
ASLN stock volume for the day was 769.82K shares. The average number of ASLN shares traded daily for last 3 months was 102.49K.
The market value of ASLN currently stands at $1.70M with its latest stock price at $0.60 and 2.83M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com